Drug · DIN 02247998
SERC
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 20, 2016; first marketed December 10, 2003.
- Drug Identification Number (DIN)
- 02247998
- Company (DIN owner)
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Betahistine N07CA01
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BETAHISTINE HYDROCHLORIDE | 24 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 7, 2015: NOC 16495New Drug Submission (NDS) · Transfer of drug identification numbers
- January 4, 2011: NOC 11980New Drug Submission (NDS) · Manufacturer name change
- May 28, 2010: NOC 11442New Drug Submission (NDS) · Manufacturer name change
- September 5, 2003: NOC 155Supplement to a New Drug Submission (SNDS) · New strength: tablet 24 mg
Other DINs named SERC
- DIN 02243878 · Marketed